Algernon Pharmaceuticals Financial Overview
Algernon Pharmaceuticals's market cap is currently C$2.74M. The company's EPS TTM is C$-0.02; its P/E ratio is -1.27; Algernon Pharmaceuticals is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
